S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
S&P 500   4,229.45 (-1.37%)
DOW   33,002.38 (-1.29%)
QQQ   354.92 (-1.75%)
AAPL   172.40 (-0.78%)
MSFT   313.39 (-2.61%)
META   300.94 (-1.92%)
GOOGL   132.43 (-1.30%)
AMZN   124.72 (-3.66%)
TSLA   246.53 (-2.02%)
NVDA   435.17 (-2.82%)
NIO   8.61 (-2.05%)
BABA   84.54 (-2.30%)
AMD   100.08 (-3.09%)
T   14.78 (+0.75%)
F   12.07 (-1.95%)
MU   67.83 (-0.19%)
CGC   0.68 (-7.30%)
GE   107.76 (-0.95%)
DIS   79.54 (-2.61%)
AMC   7.85 (-3.68%)
PFE   33.90 (-0.12%)
PYPL   57.30 (-2.15%)
NFLX   376.75 (-0.94%)
NASDAQ:BCAB

BioAtla (BCAB) Earnings Date, Estimates & Call Transcripts

$1.51
-0.12 (-7.36%)
(As of 04:00 PM ET)
Compare
Today's Range
$1.50
▼
$1.66
50-Day Range
$1.63
▼
$3.00
52-Week Range
$1.50
▼
$11.73
Volume
246,054 shs
Average Volume
512,721 shs
Market Capitalization
$72.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.83
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 3Estimated
Actual EPS
(Aug. 1)
-$0.75 Missed By -$0.13
Consensus EPS
(Aug. 1)
-$0.62
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

BCAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BCAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioAtla Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20231($0.65)($0.65)($0.65)
Q3 20231($0.71)($0.71)($0.71)
Q4 20231($0.72)($0.72)($0.72)
20233($2.08)($2.08)($2.08)
Q1 20241($0.62)($0.62)($0.62)
Q2 20241($0.60)($0.60)($0.60)
Q3 20241($0.58)($0.58)($0.58)
Q4 20241($0.53)($0.53)($0.53)
FY 20244($2.33)($2.33)($2.33)

BCAB Earnings Date and Information

BioAtla last issued its quarterly earnings results on August 1st, 2023. The reported ($0.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.62) by $0.13. BioAtla has generated ($2.65) earnings per share over the last year (($2.65) diluted earnings per share). Earnings for BioAtla are expected to grow in the coming year, from ($2.82) to ($2.40) per share. BioAtla has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 3rd, 2023 based off prior year's report dates.

BioAtla Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/3/2023
Estimated)		------- 
8/1/2023Q2 2023($0.62)($0.75)($0.13)($0.75)--
5/11/2023Q1 2023($0.66)($0.58)+$0.08($0.58)--
3/23/2023Q4 2022($0.74)($0.63)+$0.11($0.63)--
11/4/2022Q3 2022($0.77)($0.69)+$0.08($0.69)--
8/9/2022Q2 2022($0.70)($0.77)($0.07)($0.77)--    
5/5/2022Q1 2022($0.69)($0.65)+$0.04($0.65)--
3/1/2022Q4 2021($0.72)($0.63)+$0.09($0.63)--
11/15/2021Q3($0.6440)($0.68)($0.0360)($0.68)--
8/12/2021Q2 2021($0.56)($0.90)($0.34)($0.90)-$0.25 million
5/11/2021Q1($0.5230)($0.56)($0.0370)($0.56)--
3/24/2021Q4($0.7790)($1.50)($0.7210)---












BioAtla Earnings - Frequently Asked Questions

When is BioAtla's earnings date?

BioAtla has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 3rd, 2023 based off last year's report dates. Learn more on BCAB's earnings history.

Did BioAtla beat their earnings estimates last quarter?

In the previous quarter, BioAtla (NASDAQ:BCAB) missed the analysts' consensus estimate of ($0.62) by $0.13 with a reported earnings per share (EPS) of ($0.75). Learn more on analysts' earnings estimate vs. BCAB's actual earnings.

How much revenue does BioAtla generate each year?

BioAtla (NASDAQ:BCAB) has a recorded annual revenue of $250,000.00.

How much profit does BioAtla generate each year?

BioAtla (NASDAQ:BCAB) has a recorded net income of -$106.48 million. BCAB has generated -$2.65 earnings per share over the last four quarters.

What is BioAtla's EPS forecast for next year?

BioAtla's earnings are expected to grow from ($2.82) per share to ($2.40) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:BCAB) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -